CytomX Therapeutics, Inc. CTMX
2.14 USD -0.21 (-8.94%)
At closeNov 5, 2026, 7:16 PM EST
2.11 -0.03 -1.30%
After hours · Nov 5, 7:16 PM ET
2.11 Day range 2.35
2.14 52-week range 6.75
- YTD
- -49.77%
- 1 year
- -49.17%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 76.20M | 138.10M | 101.21M | 53.16M | 37.31M | |
| 76.20M | 138.10M | 101.21M | 53.16M | 37.31M | |
| -22.36M | 25.00M | -6.48M | -101.33M | -116.04M | |
| -17.37M | 31.87M | -569.00K | -99.32M | -115.87M | |
| -0.15 | 0.38 | -0.01 | -1.51 | -1.81 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 14.19M | 39.08M | 18.09M | 194.57M | 206.45M | |
| 151.57M | 120.53M | 201.79M | 260.89M | 339.41M | |
| 52.56M | 120.99M | 249.24M | 346.64M | 339.87M | |
| 4.24M | 9.38M | 13.97M | 18.06M | 18.06M | |
| 99.01M | -456.00K | -47.45M | -85.75M | -459.00K |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -75.59M | -86.23M | -56.03M | -110.79M | -119.03M | |
| -59.74M | 99.70M | -150.67M | 98.26M | 22.49M | |
| 110.45M | 7.52M | 30.23M | 648.00K | 110.21M | |
| -220.00K | -310.00K | -840.00K | -1.74M | -1.61M | |
| -24.89M | 20.99M | -176.48M | -11.88M | 13.67M |